Supplementary File 3: Dose Limiting Toxicity. from Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer

Authors :: Baukelien van Triest
Marcel Verheij
Neeltje Steeghs
Jan H.M. Schellens
Conchita Vens
Manon Verwijs-Janssen
Dick Pluim
Ferry Lalezari
Adrianus J. de Langen
Erik van Werkhoven
Heike M.U. Peulen
Judi van Diessen
Michel M. van den Heuvel
Rosemarie de Haan
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: This file contains details on DLT (I) and DLT probabilities according to TITE-CRM in the CCRT arm (II) and (SC)RT study arm (III).

Tools